Ina Lee, M.D., Ph.D.
Dr. Lee is a molecular pathologist in NCI COMPASS, which provides state-of-the-art clinical sequencing services to CCR principal investigators. Her interests include genomic features of hematologic malignancies, integrated precision diagnostics and monitoring of hematolymphoid neoplasms, and the underlying biology of myeloid neoplasms.
1) neoplasm molecular genomics, 2) hematolymphoid neoplasia
Dr. Lee is currently involved in clinical utilitization of developing molecular technologies for precision diagnostics in the setting of malignant and pre-malignant neoplasia. She is specifically interested in the integration of molecular genetics and genomics testing into multidisciplinary diagnostic and monitoring strategies for hematolymphoid neoplasms.
Selected Key Publications
Jumping translocations of chromosome 1q occurring by a multi-stage process in an acute myeloid leukemia progressed from myelodysplastic syndrome with a TET2 mutation.Mol Cytogenet. 12: 47, 2019. [ Journal Article ]
Posttransplant Classic Hodgkin Lymphoma: Richter Transformation or Posttransplant Lymphoproliferative Disorder?.AJSP: Reviews & Reports. 24: 212-217, 2019. [ Journal Article ]
- Viruses. 10(5): 233, 2018. [ Journal Article ]
Dr. Lee earned her M.D. and Ph.D. through the Medical Scientist Training Program at the University of Illinois at Chicago School of Medicine. She then completed a combined pathology residency (AP/CP) and hematopathology fellowship at the University of Maryland Medical Center in Baltimore, MD, followed by a Molecular Genetic Pathology fellowship at the University of North Carolina, Chapel Hill, NC.